Figure 5.

(A) Discriminant plots separating the four dietary treatments (Control; CON red, ground grape pomace; GGP green, dried winery yeast cell walls; WYC blue, and phenolic extract from grape stems included in soluble starch; PE purple) according to pooled data of the liver’s relative transcript levels and blood plasma and breast muscle antioxidant indicators. (B) Principal component analyses were applied on liver relative transcript levels, blood plasma, and breast muscle antioxidant indicators. L_CAT: catalase relative expression in liver; L_SOD1: superoxide dismutase 1 relative expression in liver; L_GPX1: glutathione peroxidase 1 relative expression in liver; L_GPX2: glutathione peroxidase 2 relative expression in liver; L_iNOS: nitrous oxide relative expression in liver; L_NOX1: NADPH oxidase 1 relative expression in liver; L_NOX2: NADPH oxidase 2 relative expression in liver; L_NOX3: NADPH oxidase 3 relative expression in liver; L_GST: glutathione transferase 2A relative expression in liver; B_FRAP: blood plasma FRAP value; B_ABTS: blood plasma ABTS value; B_DPPH: blood plasma DPPH value; B_MDA: blood plasma MDA concentration; B_CAT: catalase activity in blood plasma; B_SOD: superoxide dismutase activity in blood plasma; B_GPX: glutathione peroxidase activity in blood plasma; B_GST: glutathione transferase activity in blood plasma; B_GR: glutathione reductase activity in blood plasma; M_FRAP: FRAP value in breast muscle; M_ABTS: ABTS value in breast muscle; M_DPPH: DPPH value in breast muscle; M_MDA: MDA concentration in breast muscle.